🇺🇸 CRL — Charles River Laboratories International, Inc.

Salud Compra
← Volver

Precio actual

326,29 USD

Máx. histórico

458,30

1867 días

Caída desde máximo

-28,80%

Rango 52 semanas

146,20 – 379,63

Variación hoy

-7,27%

Cierre anterior

351,87

Rango de hoy

325,35 – 354,99

Volumen hoy

1.728.177

Peor caída histórica

-78,23%

24/09/2021 → 11/04/2025

Aún sin recuperar

Volatilidad anualizada ⓘ

35,93%

Información
Nombre completo
Charles River Laboratories International, Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Diagnostics & Research
Empleados
18.300
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
318,87 USD (puede no estar actualizado)
Primera cotización
23/06/2000
Precio actualizado
hace 13 horas
Sobre la empresa

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization; and Medigen Vaccine Biologics Corp for developing next-generation multivalent enterovirus vaccine, enhance global regulatory readiness, and support IND-enabling non-clinical studies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/10/2017 110,57 110,82 109,50 110,46 +0,51% 1,19% 221.300
06/10/2017 109,91 110,59 109,27 109,90 -0,20% 1,20% 207.200
05/10/2017 109,72 110,52 109,02 110,12 +0,49% 1,37% 373.100
04/10/2017 109,30 109,74 108,78 109,58 +0,24% 0,88% 268.800
03/10/2017 108,92 109,42 108,61 109,32 +0,36% 0,74% 293.800
02/10/2017 108,05 109,00 107,99 108,93 +0,84% 0,93% 443.400
29/09/2017 106,94 108,41 106,84 108,02 +1,02% 1,47% 330.900
28/09/2017 106,90 107,34 106,47 106,93 -0,09% 0,81% 295.200
27/09/2017 105,96 107,31 105,89 107,03 +1,52% 1,34% 297.800
26/09/2017 105,82 106,19 105,00 105,43 -0,39% 1,12% 328.700
25/09/2017 105,24 106,33 104,45 105,84 +0,31% 1,79% 250.900
22/09/2017 105,52 105,83 104,30 105,51 +0,12% 1,45% 428.700
21/09/2017 105,68 105,97 105,22 105,38 -0,40% 0,71% 229.600
20/09/2017 105,58 106,48 105,13 105,80 +0,11% 1,28% 571.100
19/09/2017 107,25 107,32 105,52 105,68 -1,50% 1,68% 404.600
18/09/2017 106,35 107,47 105,87 107,29 +1,20% 1,50% 401.100
15/09/2017 106,02 106,53 105,32 106,02 -0,27% 1,14% 572.900
14/09/2017 107,36 108,22 106,07 106,31 -1,13% 2,00% 489.500
13/09/2017 109,16 109,43 107,39 107,53 -1,58% 1,87% 552.800
12/09/2017 108,66 109,26 108,06 109,26 +0,64% 1,10% 462.300
11/09/2017 108,93 108,93 107,86 108,57 +0,36% 0,98% 493.600
08/09/2017 108,71 109,59 108,07 108,18 -0,98% 1,40% 485.200
07/09/2017 108,25 109,27 107,31 109,25 +1,29% 1,81% 353.600
06/09/2017 108,15 108,27 106,84 107,86 +0,38% 1,32% 450.900
05/09/2017 107,95 108,91 106,90 107,45 -0,71% 1,86% 357.000
01/09/2017 108,93 109,38 108,08 108,22 -0,53% 1,19% 326.700
31/08/2017 107,07 108,85 107,07 108,80 +1,87% 1,66% 396.600
30/08/2017 106,21 107,39 105,94 106,80 +0,35% 1,37% 347.200
29/08/2017 105,86 106,64 105,66 106,43 +0,59% 0,93% 469.100
28/08/2017 105,27 106,44 105,10 105,81 +0,74% 1,27% 346.500